Cargando…
Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial
BACKGROUND: In this study, a combination of recombinant adenoviral p53 (rAd-p53) gene therapy and intra-arterial delivery of chemotherapeutic agents for treatment of oral squamous cell carcinoma was evaluated. METHODS: In total, 99 patients with stage III or IV oral carcinoma who had refused or were...
Autores principales: | Li, Yi, Li, Long-Jiang, Wang, Li-Juan, Zhang, Zhuang, Gao, Ning, Liang, Chen-Yuan, Huang, Yuan-Ding, Han, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922639/ https://www.ncbi.nlm.nih.gov/pubmed/24479409 http://dx.doi.org/10.1186/1741-7015-12-16 |
Ejemplares similares
-
rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
por: Montefiori, DC, et al.
Publicado: (2012) -
Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Intra-arterial infusion chemotherapy in the treatment of advanced basosquamous carcinoma of the nose
por: Sheen, Yen-Ting, et al.
Publicado: (2021) -
Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
por: Liu, Xiaoyu, et al.
Publicado: (2016) -
Case report of a huge lower lip cancer successfully treated with intra-arterial infusion chemotherapy
por: Sheen, Yen Ting, et al.
Publicado: (2020)